The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The p53 tumor suppressor protein, a modulator of cell proliferation.
Open accessAbstract
p53 was first described as a cellular protein which co-precipitated with the large T antigen of simian virus 40 (SV40) and whose synthesis was enhanced in chemically transformed tumors (1-3).Intense research has resulted in isolation of clones for homologous-p53 cDNAs and genes from diverse organisms (Fig. 1) and extensive characterization of the encoded nuclear phosphoprotein (reviewed in Ref. 4).Genetic evidence suggests that the p53 gene is a member of a family of tumor suppressor genes (5-7).p53 is the gene most frequently found to be mutated in a wide variety of human tumors (8).The molecular mechanisms of p53 function remain unknown; however, accumulating evidence suggests that p53 regulates expression of cell cycle-related genes (9, 10).p53 appears to have two conformations (11, 12); one is associated with the ability to block cell cycle progression and is unique to the wild type (wt)' protein; the second is associated with the ability to promote cell proliferation and may be common to mutant forms and wt-p53 alike.The ability to switch between two conformational states could explain apparently contradictory properties of p53 in normal cells.Recent reviews have focused on the structure of p53 and its role in cancer (4,(13)(14)(15).Here, we focus on the role of p53 in controlling cell proliferation, and we review recent data which show how post-translational modifications may regulate p53 conformation to produce both growthstimulating and growth-inhibiting effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6565 · Cited by 356
Cited by
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Harris, C. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1442 · Cited by 680
Causes and Consequences of Increased Glucose Metabolism of Cancers
Gillies, R. J., Robey, I., & Gatenby, R. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047258 · Cited by 623
Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., & Anderson, C. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5041 · Cited by 487
Self-citationFunctional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Self-citation
Metadata
- Authors
- Ullrich, S. J., Anderson, C. W., Mercer, W. E., & Appella, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1992-08
- Volume
- 267
- Issue
- 22
- Pages
- 15259-15262
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1922148398
- Cited by
- 168
- References
- 4
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The p53 tumor suppressor protein, a modulator of cell proliferation. https://app.cochat.ai/papers/10.1016/s0021-9258(19)49524-0
- The paper
- Ullrich, S. J., Anderson, C. W., Mercer, W. E., & Appella, E. (1992). The p53 tumor suppressor protein, a modulator of cell proliferation. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)49524-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.